Annual Report

Amphastar Pharmaceuticals, Inc. Filed 2022-03-11 Acc 0001297184-22-000007

Documents 1

2023-03-01 10-K Annual Report
2022-03-17 4 CEO & Chief Scientific Officer gave up 19,545 shares (to pay taxes)
2022-03-11 S-8 Securities Offered to Employees in Benefit Plans
2022-03-11 10-K Annual Report
2022-03-10 8-K Results of operations
2022-03-09 4 CFO, EVP & Treasurer sold 13,026 shares at $29.35 ($382,313)
2021-03-15 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading amph-20211231x10k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…